Description

• General description: Mirtazapine is a tetracyclic antidepressant marketed under the trade names Remeron®, Avanza, or Zispin for treatment of depression. This Certified Spiking Solution® is suitable for LC/MS or GC/MS applications in forensic analysis, clinical toxicology, or urine drug testing.
• Application: Mirtazapine research solution for CNS studies: A study on the nose-to-brain delivery of mirtazapine via lipid nanocapsules highlights its potential for enhanced CNS targeting, offering a promising approach for treating neurological conditions. This method aims to improve the bioavailability and therapeutic effectiveness of mirtazapine, showcasing its utility in pharmacokinetic research and CNS depressant studies (Ibrahim et al., 2024).Mirtazapine liquid formulation for orally disintegrating tablets: Research into developing a novel direct compressible co-processed excipient for the formulation of mirtazapine orally disintegrating tablets emphasizes its importance in enhancing patient compliance and dosing accuracy. This study demonstrates mirtazapine′s role in pharmaceutical formulations, ensuring rapid onset of action which is critical in acute management of depressive episodes (Loke et al., 2024).High-purity mirtazapine liquid for neurotransmitter research: A review linking stress, depression, and insulin resistance explores the systemic effects of chronic inflammation and the role of treatments like mirtazapine. This research underscores the importance of mirtazapine in understanding the biochemical pathways involved in chronic mental health disorders and their somatic comorbidities (Mehdi et al., 2023).Stable mirtazapine formulation for opioid withdrawal treatment: Mirtazapine is explored as a one-stop strategy for the treatment of opioid withdrawal symptoms, highlighting its efficacy in reducing withdrawal severity and potentially lowering the dependency on traditional opioid replacement therapies. This application provides insights into mirtazapine′s versatility in treating complex drug dependencies (Lalani et al., 2023).Mirtazapine aqueous solution for pharmacokinetic profiling: Research on the simultaneous separation and determination of several chiral antidepressants, including mirtazapine, in wastewater by two-dimensional liquid chromatography offers critical insights into environmental exposure and bioaccumulation risks. This study is pivotal for environmental safety and pharmaceutical dispersion monitoring, reflecting mirtazapine′s impact beyond clinical settings (Zhong et al., 2023).
• Legal Information: CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany